Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population

Detalles Bibliográficos
Autores principales: Kockerols, Camille C.B., Janssen, Jeroen J.W.M, Blijlevens, Nicole M.A., Klein, Saskia K., van Hussen-Daenen, Laura G.M., van Gorkom, Gwendolyn G.Y., Smit, Willem M., van Balen, Peter, Biemond, Bart J., Cruijsen, Marjan J., Corsten, Maarten F., te Boekhorst, Peter A.W., Koene, Harry R., van Sluis, Geerte L., Cornelissen, Jan J., Westerweel, Peter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827157/
https://www.ncbi.nlm.nih.gov/pubmed/36073515
http://dx.doi.org/10.3324/haematol.2022.281386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827157/
https://www.ncbi.nlm.nih.gov/pubmed/36073515
http://dx.doi.org/10.3324/haematol.2022.281386

Ejemplares similares